Cargando…
A Case Report and Literature Review of the Outcome of Linezolid-Induced Optic and Peripheral Neuropathy in Patients With Multidrug-Resistant Pulmonary TB
Linezolid is a second-line medication used to treat tuberculosis that has become resistant to multiple drugs. Linezolid has been shown to be effective in treating drug-resistant TB. However, long-term therapy is hampered by the related side effects, such as ocular and peripheral neuropathy. We recen...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263968/ https://www.ncbi.nlm.nih.gov/pubmed/35812114 http://dx.doi.org/10.3389/fneur.2022.908584 |
_version_ | 1784742867335380992 |
---|---|
author | Bano, Safia Nawaz, Ahmad Numan, Ahsan Hassan, Muhammad Aarish Shafique, Muhammad Bilal Ahmad |
author_facet | Bano, Safia Nawaz, Ahmad Numan, Ahsan Hassan, Muhammad Aarish Shafique, Muhammad Bilal Ahmad |
author_sort | Bano, Safia |
collection | PubMed |
description | Linezolid is a second-line medication used to treat tuberculosis that has become resistant to multiple drugs. Linezolid has been shown to be effective in treating drug-resistant TB. However, long-term therapy is hampered by the related side effects, such as ocular and peripheral neuropathy. We recently encountered a 32-year-old male undergoing linezolid therapy for 12 months for multidrug-resistant tuberculosis who presented with progressive painless visual impairment and peripheral neuropathy symptoms in lower limbs as well as ataxic gait. Nerve conduction study findings of length-dependent axonal sensory polyneuropathy with bilateral optic neuropathy evident on fundoscopy suggested a case of toxic neuropathy. Following the termination of linezolid, follow-up visits revealed an improvement in visual symptoms. While there has been no discernible improvement or deterioration of peripheral neuropathy. In a developing country like Pakistan, where the rising number of cases of multidrug-resistant tuberculosis and its management is a major problem, physicians should be made aware of linezolid induced neuropathy so that close follow-up sessions for patients on long-term linezolid therapy can be arranged to avoid serious neurological consequences. |
format | Online Article Text |
id | pubmed-9263968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92639682022-07-09 A Case Report and Literature Review of the Outcome of Linezolid-Induced Optic and Peripheral Neuropathy in Patients With Multidrug-Resistant Pulmonary TB Bano, Safia Nawaz, Ahmad Numan, Ahsan Hassan, Muhammad Aarish Shafique, Muhammad Bilal Ahmad Front Neurol Neurology Linezolid is a second-line medication used to treat tuberculosis that has become resistant to multiple drugs. Linezolid has been shown to be effective in treating drug-resistant TB. However, long-term therapy is hampered by the related side effects, such as ocular and peripheral neuropathy. We recently encountered a 32-year-old male undergoing linezolid therapy for 12 months for multidrug-resistant tuberculosis who presented with progressive painless visual impairment and peripheral neuropathy symptoms in lower limbs as well as ataxic gait. Nerve conduction study findings of length-dependent axonal sensory polyneuropathy with bilateral optic neuropathy evident on fundoscopy suggested a case of toxic neuropathy. Following the termination of linezolid, follow-up visits revealed an improvement in visual symptoms. While there has been no discernible improvement or deterioration of peripheral neuropathy. In a developing country like Pakistan, where the rising number of cases of multidrug-resistant tuberculosis and its management is a major problem, physicians should be made aware of linezolid induced neuropathy so that close follow-up sessions for patients on long-term linezolid therapy can be arranged to avoid serious neurological consequences. Frontiers Media S.A. 2022-06-24 /pmc/articles/PMC9263968/ /pubmed/35812114 http://dx.doi.org/10.3389/fneur.2022.908584 Text en Copyright © 2022 Bano, Nawaz, Numan, Hassan and Shafique. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Bano, Safia Nawaz, Ahmad Numan, Ahsan Hassan, Muhammad Aarish Shafique, Muhammad Bilal Ahmad A Case Report and Literature Review of the Outcome of Linezolid-Induced Optic and Peripheral Neuropathy in Patients With Multidrug-Resistant Pulmonary TB |
title | A Case Report and Literature Review of the Outcome of Linezolid-Induced Optic and Peripheral Neuropathy in Patients With Multidrug-Resistant Pulmonary TB |
title_full | A Case Report and Literature Review of the Outcome of Linezolid-Induced Optic and Peripheral Neuropathy in Patients With Multidrug-Resistant Pulmonary TB |
title_fullStr | A Case Report and Literature Review of the Outcome of Linezolid-Induced Optic and Peripheral Neuropathy in Patients With Multidrug-Resistant Pulmonary TB |
title_full_unstemmed | A Case Report and Literature Review of the Outcome of Linezolid-Induced Optic and Peripheral Neuropathy in Patients With Multidrug-Resistant Pulmonary TB |
title_short | A Case Report and Literature Review of the Outcome of Linezolid-Induced Optic and Peripheral Neuropathy in Patients With Multidrug-Resistant Pulmonary TB |
title_sort | case report and literature review of the outcome of linezolid-induced optic and peripheral neuropathy in patients with multidrug-resistant pulmonary tb |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263968/ https://www.ncbi.nlm.nih.gov/pubmed/35812114 http://dx.doi.org/10.3389/fneur.2022.908584 |
work_keys_str_mv | AT banosafia acasereportandliteraturereviewoftheoutcomeoflinezolidinducedopticandperipheralneuropathyinpatientswithmultidrugresistantpulmonarytb AT nawazahmad acasereportandliteraturereviewoftheoutcomeoflinezolidinducedopticandperipheralneuropathyinpatientswithmultidrugresistantpulmonarytb AT numanahsan acasereportandliteraturereviewoftheoutcomeoflinezolidinducedopticandperipheralneuropathyinpatientswithmultidrugresistantpulmonarytb AT hassanmuhammadaarish acasereportandliteraturereviewoftheoutcomeoflinezolidinducedopticandperipheralneuropathyinpatientswithmultidrugresistantpulmonarytb AT shafiquemuhammadbilalahmad acasereportandliteraturereviewoftheoutcomeoflinezolidinducedopticandperipheralneuropathyinpatientswithmultidrugresistantpulmonarytb AT banosafia casereportandliteraturereviewoftheoutcomeoflinezolidinducedopticandperipheralneuropathyinpatientswithmultidrugresistantpulmonarytb AT nawazahmad casereportandliteraturereviewoftheoutcomeoflinezolidinducedopticandperipheralneuropathyinpatientswithmultidrugresistantpulmonarytb AT numanahsan casereportandliteraturereviewoftheoutcomeoflinezolidinducedopticandperipheralneuropathyinpatientswithmultidrugresistantpulmonarytb AT hassanmuhammadaarish casereportandliteraturereviewoftheoutcomeoflinezolidinducedopticandperipheralneuropathyinpatientswithmultidrugresistantpulmonarytb AT shafiquemuhammadbilalahmad casereportandliteraturereviewoftheoutcomeoflinezolidinducedopticandperipheralneuropathyinpatientswithmultidrugresistantpulmonarytb |